The stock market witnessed a striking debut from Sheel Biotech, as its shares listed at Rs 91 apiece on the NSE Emerge platform on October 8. This represents a substantial premium of 44.44% over the IPO price of Rs 63. Investors showed a clear appetite for this new entrant, making headlines in the stock market today.
Market Performance: A Strong Debut
The listing of Sheel Biotech shares signals investor confidence in the company’s offerings. Right from the opening bell:
- Listing Price: Rs 91 per share
- IPO Price: Rs 63 per share
- Premium on Listing: 44.44%
The surge reflects the strong demand the IPO garnered, making it one of the most talked-about listings on the NSE Emerge platform this week.
About Sheel Biotech: Company Overview
Sheel Biotech operates in the biotechnology sector with a focus on innovative and sustainable solutions. Its offerings include:
- Development, processing, and supply of biotechnology-related products
- Floriculture and greenhouse solutions
- Organic adoption and certification services
- Turnkey projects for bio-agriculture and floriculture
This diversified portfolio has positioned Sheel Biotech as a noteworthy player in its sector, attracting attention from investors across institutions and retail segments.
Sheel Biotech IPO: Key Details
The company had launched its IPO to raise over Rs 34 crore entirely through a fresh issue of shares. Key highlights include:
- IPO Price Band: Rs 59–63 per share
- Minimum Investment: 2,000 shares (Rs 1.26 lakh at upper band)
- IPO Duration: September 30 – October 3
The IPO attracted robust investor interest, making it one of the most subscribed offerings recently:
- Qualified Institutional Buyers (QIB): Subscribed nearly 20 times
- Non-Institutional Investors (NII): Subscribed 19.5 times
- Retail Investors: Portion booked around 10 times
This overwhelming response reflects the high demand for Sheel Biotech’s shares in the primary market.
Summary of Sheel Biotech Share Listing
In short, the market debut of Sheel Biotech has been impressive:
- Shares listed at a 44% premium to IPO price
- Strong subscription from institutional, non-institutional, and retail investors
- Company positioned in a high-growth biotechnology sector
- IPO raised Rs 34 crore via fresh issuance
For investors tracking Sheel Biotech share price in the stock market today, this debut underlines the strong market interest and sets a positive tone for its trading journey.
